Overexpression of GAMT restores GAMT activity in primary GAMT-deficient fibroblasts

被引:6
作者
Almeida, L. S. [1 ]
Rosenberg, E. H. [1 ]
Martinez-Munoz, C. [1 ]
Verhoeven, N. M. [1 ]
Vilarinho, L. [1 ]
Jakobs, C. [1 ]
Salomons, G. S. [1 ]
机构
[1] VU Univ, Med Ctr, Dept Clin Chem, Metab Unit, Amsterdam, Netherlands
关键词
cerebral creatine deficiency syndrome; GAMT; mental retardation; transfection;
D O I
10.1016/j.ymgme.2006.06.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Guanidinoacetate methyltransferase deficiency (MIM 601240) is an autosomal recessive disorder of creatine biosynthesis. Patients present with mental retardation, extrapyramidal symptoms, autistic-like behavior, epilepsy, cerebral creatine deficiency and increased levels of guanidinoacetate. So far 15 mutations have been reported, including six missense variants that are highly likely to be pathogenic mutations. To prove that mutations in the GAMT gene are responsible for GAMT deficiency we overexpressed the GAMT open reading frame in GAMT-deficient fibroblasts by stable transfection. In addition, HeLa cells were transiently transfected with the same expression vector. In contrast to mock transfectants transfection of primary GAMT-deficient fibroblasts with wild-type GAMT results in the restoration of GAMT activity as measured by GC-MS using stable isotope labeled substrates. Moreover, the expression of the GAMT-EGFP fusion protein was analyzed by Western blot, confirming the presence of GAMT fusion protein, both in the stable as well as in the transient transfectants. Here, we prove that mutations in the GA MT gene are responsible for GAMT deficiency, since overexpression of the GAMT open reading frame restores GAMT activity in GAMT-deficient fibroblasts. Furthermore, the transient transfection of HeLa cells will be important for functional analysis of variants of unknown consequence (i.e., missense mutations). (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:392 / 394
页数:3
相关论文
共 11 条
  • [1] Prenatal diagnosis of guanidinoacetate methyltransferase deficiency:: Increased guanidinoacetate concentrations in amniotic fluid
    Cheillan, D
    Salomons, GS
    Acquaviva, C
    Boisson, C
    Roth, P
    Cordier, MP
    François, L
    Jakobs, C
    Vianey-Saban, C
    [J]. CLINICAL CHEMISTRY, 2006, 52 (04) : 775 - 777
  • [2] Item C B, 2004, Hum Mutat, V23, P524, DOI 10.1002/humu.9238
  • [3] MERCIMEKMAHMUTO.S, 2003, UNPUB NEUROLOGY
  • [4] Overexpression of wild-type creatine transporter (SLC6A8) restores creatine uptake in primary SLC6A8-deficient fibroblasts
    Rosenberg, EH
    Muñoz, CM
    Degrauw, TJ
    Jakobs, C
    Salomons, GS
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 (2-3) : 345 - 346
  • [5] Creatine deficiency syndromes
    Schulze, A
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2003, 244 (01) : 143 - 150
  • [6] Improving treatment of guanidinoacetate methyltransferase deficiency: Reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation
    Schulze, A
    Ebinger, F
    Rating, D
    Mayatepek, E
    [J]. MOLECULAR GENETICS AND METABOLISM, 2001, 74 (04) : 413 - 419
  • [7] SCHULZE A, 2006, IN PRESS NEUROLOGY
  • [8] Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis
    Stockler, S
    Marescau, B
    DeDeyn, PP
    Trijbels, JMF
    Hanefeld, F
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (10): : 1189 - 1193
  • [9] Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism
    Stockler, S
    Hanefeld, F
    Frahm, J
    [J]. LANCET, 1996, 348 (9030) : 789 - 790
  • [10] Stockler S, 1996, AM J HUM GENET, V58, P914